Search

371 results found

Showing results 271 to 280.

Annual Report 2024

Note 10 Trade and other receivables

At the end of the financial year, impairment of receivables totalled €12 million (2023: €11 million). The impairment of receivables recognised in the income statement in 2024 as an expense amounted to €5 million (2023: €3 million).

Read more
Annual Report 2024

Note 11 Cash and cash equivalents

The effective interest rate on cash and cash equivalents ranged from 2.9% to 4.0% (2023: 0.0% to 4.3%). Cash and cash equivalents are held almost entirely in euros.

Read more
Annual Report 2024

Note 12 Equity

The company’s authorised capital is divided into 350 million shares of €5 nominal value. As at year-end 2024, 136,794,964 shares were in issue (2023: 136,794,964).

Read more
Annual Report 2024

Note 13 Interest-bearing debt

The movements in new loans, repayments and security deposit repayments during the year gave rise to cash flows.

Read more
Annual Report 2024

Note 14 Deferred income

Deferred income relates to construction contributions, investment grants and subsidies received.

Read more
Annual Report 2024

Note 15 Provisions for employee benefits

Prompted by the deterioration of the funding ratio in 2008, ABP introduced a recovery plan in 2009. At the start of each year ABP evaluates the progress of the recovery on the basis of the actual funding ratio at the end of the preceding year.

Read more
Annual Report 2024

Note 16 Other provisions

The other provisions as at year-end 2024 amounted to €30 million (2023: €11 million).

Read more
Annual Report 2024

Note 17 Deferred tax

Deferred tax assets and liabilities comprise the following:

Read more
Annual Report 2024

Note 18 Trade and other payables

Other payables include €12 million owed to a company in which Alliander has a non-controlling interest (2023: €32 million).

Read more
Annual Report 2024

Note 19 Leases

Finance lease receivables are as follows:

Read more
Page: